BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Business

  Echo Therapeutics Announces Warrant Exercise by Its Largest Shareholder

  November 2, 2011

   · 

  3 min read
• Business

  Patheon Announces a Change to its Management Structure

  November 2, 2011

   · 

  1 min read
• Drug Development

  Medivir AB Announces Final Results from TMC435 Phase IIb ASPIRE (C206) Study

  November 2, 2011

   · 

  9 min read
• Business

  Transcept Pharmaceuticals, Inc. to Report Third Quarter 2011 Financial Results and Host Conference Call on November 10, 2011

  November 2, 2011

   · 

  1 min read
• Pharm Country

  Invivodata, Inc. and PRO Consulting Extend Educational Webinar Series

  November 2, 2011

   · 

  4 min read
• Business

  Halozyme Therapeutics, Inc. to Host Third Quarter 2011 Financial Results Conference Call on November 7

  November 2, 2011

   · 

  2 min read
• Genetown

  Quanterix Fifth-Generation PSA Test Enables More Sensitive Measurements Following Surgery

  November 2, 2011

   · 

  2 min read
• Pharm Country

  Misonix Incorporated Announces its Exhibition at the European Association of Neurosurgical Societies

  November 2, 2011

   · 

  3 min read
• Business

  GenVec Inc. to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011

  November 2, 2011

   · 

  1 min read
• Genetown

  Millennium: The Takeda Oncology Company Release: FDA Approves Addition of Sustained Overall Survival Advantage (5-year Follow-up) to Label for VELCADE® in Patients with Previously Untreated Multiple Myeloma

  November 2, 2011

   · 

  1 min read